Creating a smartphone tool to quickly detect pesticide exposure
Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides
['FUNDING_OTHER'] · NANODIAGNOSTIC TECHNOLOGY, LLC · NIH-11052455
This study is working on a handy device that connects to your smartphone to quickly and accurately check for pesticide exposure using just a tiny drop of your blood, making it easier for people affected by pesticide poisoning to get the care they need without waiting for lab results.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NANODIAGNOSTIC TECHNOLOGY, LLC (nih funded) |
| Locations | 1 site (KANNAPOLIS, UNITED STATES) |
| Trial ID | NIH-11052455 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a smartphone-integrated nanosensor platform that allows for rapid and accurate detection of pesticide exposure using just a small drop of blood. The goal is to create a user-friendly tool that can be used onsite, eliminating the need for costly and time-consuming laboratory tests. By improving the sensitivity and accuracy of biomonitoring for organophosphate pesticide exposure, this project aims to enhance patient care and treatment options for those affected by pesticide poisoning.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to organophosphate pesticides, either through occupational or environmental sources.
Not a fit: Patients who are not exposed to organophosphate pesticides or those with unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a quick and reliable method to monitor pesticide exposure, leading to timely and appropriate medical interventions.
How similar studies have performed: Previous research has shown promise in developing similar biosensor technologies for biomonitoring, indicating potential for success in this novel approach.
Where this research is happening
KANNAPOLIS, UNITED STATES
- NANODIAGNOSTIC TECHNOLOGY, LLC — KANNAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, JUN — NANODIAGNOSTIC TECHNOLOGY, LLC
- Study coordinator: WANG, JUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.